BEAM
Beam Therapeutics (BEAM)
$72
About Beam Therapeutics (BEAM)
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.
Details
Daily high
$24.87
Daily low
$22.72
Price at open
$22.72
52 Week High
$49.50
52 Week Low
$16.95
Market cap
2.0B
Dividend yield
0.00%
Volume
882,870
Avg. volume
781,876
P/E ratio
-13.71
Beam Therapeutics News
Details
Daily high
$24.87
Daily low
$22.72
Price at open
$22.72
52 Week High
$49.50
52 Week Low
$16.95
Market cap
2.0B
Dividend yield
0.00%
Volume
882,870
Avg. volume
781,876
P/E ratio
-13.71